King Legacy, a wholly owned subsidiary of Pfizer

FDA Drug Class II Terminated

Levoxyl (levothyroxine sodium) tablets, USP, 137 mcg, packaged in a) 100-count bottles (NDC 60793-857-01) and b) 1000-count bottles (NDC 60793-857-10), Rx only, Manufactured and Distributed by: King

April 30, 2013 King Legacy, a wholly owned subsidiary of Pfizer 77,272 bottles units

FDA Drug Class II Terminated

Levoxyl (levothyroxine sodium) tablets, USP, 88 mcg, packaged in a) 100-count bottles (NDC 60793-853-01) and b) 1000-count bottles (NDC 60793-853-10), Rx only, Manufactured and Distributed by: King P

April 30, 2013 King Legacy, a wholly owned subsidiary of Pfizer 112,914 bottles units

FDA Drug Class II Terminated

Levoxyl (levothyroxine sodium) tablets, USP, 175 mcg, packaged in a) 100-count bottles (NDC 60793-859-01) and b) 1000-count bottles (NDC 60793-859-10), Rx only, Manufactured and Distributed by: King

April 30, 2013 King Legacy, a wholly owned subsidiary of Pfizer 51,438 bottles units

FDA Drug Class II Terminated

Levoxyl (levothyroxine sodium) tablets, USP, 25 mcg, packaged in a) 100-count bottles (NDC 60793-850-01) and b) 1000-count bottles (NDC 60793-850-10), Rx only, Manufactured and Distributed by: King P

April 30, 2013 King Legacy, a wholly owned subsidiary of Pfizer 51,591 bottles units

FDA Drug Class II Terminated

Levoxyl (levothyroxine sodium) tablets, USP, 112 mcg, packaged in a) 100-count bottles (NDC 60793-855-01) and b) 1000-count bottles (NDC 60793-855-10), Rx only, Manufactured and Distributed by: King

April 30, 2013 King Legacy, a wholly owned subsidiary of Pfizer 107,236 bottles units

FDA Drug Class II Terminated

Levoxyl (levothyroxine sodium) tablets, USP, 50 mcg, packaged in a) 100-count bottles (NDC 60793-851-01) and b) 1000-count bottles (NDC 60793-851-10), Rx only, Manufactured and Distributed by: King P

April 30, 2013 King Legacy, a wholly owned subsidiary of Pfizer 195,699 bottles units

FDA Drug Class II Terminated

Levoxyl (levothyroxine sodium) tablets, USP, 150 mcg, packaged in a) 100-count bottles (NDC 60793-858-01) and b) 1000-count bottles (NDC 60793-858-10), Rx only, Manufactured and Distributed by: King

April 30, 2013 King Legacy, a wholly owned subsidiary of Pfizer 56,405 bottles units

FDA Drug Class II Terminated

Levoxyl (levothyroxine sodium) tablets, USP, 200 mcg, packaged in a) 100-count bottles (NDC 60793-860-01) and b) 1000-count bottles (NDC 60793-860-10), Rx only, Manufactured and Distributed by: King

April 30, 2013 King Legacy, a wholly owned subsidiary of Pfizer 33,227 bottles units

FDA Drug Class II Terminated

Levoxyl (levothyroxine sodium) tablets, USP, 75 mcg, packaged in a) 100-count bottles (NDC 60793-852-01) and b) 1000-count bottles (NDC 60793-852-10), Rx only, Manufactured and Distributed by: King P

April 30, 2013 King Legacy, a wholly owned subsidiary of Pfizer 194,142 bottles units

FDA Drug Class II Terminated

Levoxyl (levothyroxine sodium) tablets, USP, 100 mcg, packaged in a) 100-count bottles (NDC 60793-854-01) and b) 1000-count bottles (NDC 60793-854-10), Rx only, Manufactured and Distributed by: King

April 30, 2013 King Legacy, a wholly owned subsidiary of Pfizer 195,201 bottles units

FDA Drug Class II Terminated

Levoxyl (levothyroxine sodium) tablets, USP, 125 mcg, packaged in a) 100-count bottles (NDC 60793-856-01) and b) 1000-count bottles (NDC 60793-856-10), Rx only, Manufactured and Distributed by: King

April 30, 2013 King Legacy, a wholly owned subsidiary of Pfizer 103,796 bottles units